These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38522841)

  • 21. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
    Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological characteristics and genome analysis of a novel phage vB_KpnP_IME279 infecting Klebsiella pneumoniae.
    Zhang R; Zhao F; Wang J; Pei G; Fan H; Zhangxiang L; Mi Z; Shi T; Liu H; Tong Y
    Folia Microbiol (Praha); 2020 Dec; 65(6):925-936. PubMed ID: 33064268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
    Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
    Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion to colistin susceptibility by tigecycline exposure in colistin-resistant Klebsiella pneumoniae and its implications to combination therapy.
    Park S; Choi J; Shin D; Kwon KT; Kim SH; Wi YM; Ko KS
    Int J Antimicrob Agents; 2024 Jan; 63(1):107017. PubMed ID: 37884228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.
    Lalaoui R; Bakour S; Livnat K; Assous MV; Diene SM; Rolain JM
    Microb Drug Resist; 2019; 25(1):63-71. PubMed ID: 30129868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    van der Weide H; Vermeulen-de Jongh DMC; van der Meijden A; Boers SA; Kreft D; Ten Kate MT; Falciani C; Pini A; Strandh M; Bakker-Woudenberg IAJM; Hays JP; Goessens WHF
    Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Klebsiella-specific phage on multidrug-resistant Klebsiella pneumoniae- an experimental study.
    Shree S; Suman E; Kotian H; Paul SH; M SS
    Indian J Med Microbiol; 2024; 47():100515. PubMed ID: 37981030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and genomic analysis of novel bacteriophage NK20 to revert colistin resistance and combat pandrug-resistant Klebsiella pneumoniae in a rat respiratory infection model.
    Al-Madboly LA; Abdelaziz AA; Abo-Kamer AM; Nosair AM; Abdelkader K
    Life Sci; 2023 Jun; 322():121639. PubMed ID: 37001805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
    Nishida S; Ono Y
    Int J Antimicrob Agents; 2020 Apr; 55(4):105854. PubMed ID: 31770626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae.
    Eskenazi A; Lood C; Wubbolts J; Hites M; Balarjishvili N; Leshkasheli L; Askilashvili L; Kvachadze L; van Noort V; Wagemans J; Jayankura M; Chanishvili N; de Boer M; Nibbering P; Kutateladze M; Lavigne R; Merabishvili M; Pirnay JP
    Nat Commun; 2022 Jan; 13(1):302. PubMed ID: 35042848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship of Hypervirulent Capsular Genotypes of Klebsiella pneumoniae with Antibiotic Susceptibility and Beta-Lactamase Genes].
    Dalğıç D; Kandemir T; Üçkayabaşı A; Nağıyev T
    Mikrobiyol Bul; 2023 Jan; 57(1):30-44. PubMed ID: 36636844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
    Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
    Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial effects of single phage and phage cocktail against multidrug-resistant Klebsiella pneumoniae isolated from diabetic foot ulcer.
    Jokar J; Saleh RO; Rahimian N; Ghasemian A; Ghaznavi G; Radfar A; Zarenezhad E; Najafipour S
    Virus Genes; 2023 Aug; 59(4):635-642. PubMed ID: 37259013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O-antigen serves as a two-faced host factor for bacteriophage NJS1 infecting nonmucoid Klebsiella pneumoniae.
    Hao G; Yuan C; Shu R; Jia Y; Zhao S; Xie S; Liu M; Zhou H; Sun S; Wang H
    Microb Pathog; 2021 Jun; 155():104897. PubMed ID: 33878399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
    Fang Q; Zong Z
    mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies.
    Xu C; Wei X; Jin Y; Bai F; Cheng Z; Chen S; Pan X; Wu W
    Microbiol Spectr; 2022 Oct; 10(5):e0139022. PubMed ID: 35972286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The secondary resistome of multidrug-resistant Klebsiella pneumoniae.
    Jana B; Cain AK; Doerrler WT; Boinett CJ; Fookes MC; Parkhill J; Guardabassi L
    Sci Rep; 2017 Feb; 7():42483. PubMed ID: 28198411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in Klebsiella pneumoniae.
    Cheng YH; Lin TL; Lin YT; Wang JT
    J Antimicrob Chemother; 2018 Jun; 73(6):1509-1516. PubMed ID: 29506266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.